Frequency Thera.

$2.01 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Frequency Thera.

Frequency Therapeutics Inc. is a United States-based clinical-stage progenitor cell activation (PCA) regeneration company. The Company is focused on developing small molecule drugs that activate progenitor cells within the body to restore healthy tissue. It uses its PCA technology to develop a pipeline of progenitor cell activators. It focuses on various therapeutic areas, such as hearing loss, skin disorders, muscle regeneration, and gastrointestinal diseases. Its lead program, FX-322, activates the regrowth of sensory cells in the inner ear to treat chronic noise induced hearing loss.

Stock Analysis

last close $2.01
1-mo return -13.7%
3-mo return 60.8%
avg daily vol. 236.95T
52-week high 8.12
52-week low 1
market cap. $78M
forward pe -
annual div. -
roe -60.5%
ltg forecast -
dividend yield -
annual rev. $9M
inst own. 34.7%

Subscribe now for daily local and international financial news